Dersalazine

CAS No. 188913-58-8

Dersalazine( —— )

Catalog No. M36326 CAS No. 188913-58-8

Dersalazine (Dersalazine Free Base), an inhibitor of platelet-activating factor, exerts intestinal anti-inflammatory activity in different rodent types of colitis by down-regulating IL-17 expression, with potential efficacy in patients with ulcerative colitis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 296 In Stock
10MG 429 In Stock
25MG 661 In Stock
50MG 920 In Stock
100MG 1237 In Stock
200MG 1655 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Dersalazine
  • Note
    Research use only, not for human use.
  • Brief Description
    Dersalazine (Dersalazine Free Base), an inhibitor of platelet-activating factor, exerts intestinal anti-inflammatory activity in different rodent types of colitis by down-regulating IL-17 expression, with potential efficacy in patients with ulcerative colitis.
  • Description
    Dersalazine (Dersalazine Free Base), an inhibitor of platelet-activating factor, exerts intestinal anti-inflammatory activity in different rodent types of colitis by down-regulating IL-17 expression, with potential efficacy in patients with ulcerative colitis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    IL Receptor
  • Recptor
    IL Receptor | Platelet aggregation
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    188913-58-8
  • Formula Weight
    600.67
  • Molecular Formula
    C35H32N6O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(N1C=2C(N=C1C)=CN=CC2)C3CCN(C(/C=C(\C4=CC=C(N=NC5=CC(C(O)=O)=C(O)C=C5)C=C4)/C6=CC=CC=C6)=O)CC3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Arjunolic acid

    Arjunolic acid has antioxidant, anti-inflammatory, antinociceptive and anticholinesterasic (AChE and BuChE) activities, it may as promising targets for the development of innovative multi-functional medicines for Alzheimer desease treatment.

  • Enokizumab

    Enokizumab?(MEDI-528) is a monoclonal antibody against interleukin IL-9. Enokizumab can be used to study asthma.

  • Tocilizumab

    Tocilizumab anti-IL-6R) is a humanized monoclonal antibody that binds to the interleukin-6 receptor.